Sep 3, 2020 | Development / Dossiers
With this ointment Polypharma is also expanding its portfolio of dermatology products. A product extremely effective for the external treatment of psoriasis. This D3 derivative disrupts the growth and proliferation of keratinocytes and improves the disturbed cell...
Aug 12, 2020 | Development / Dossiers
Polypharma has developed a cream containing the active ingredients fusidic acid and betamethasone. While fusidic acid is known to help with bacterial infections of the skin, betamethasone helps with skin diseases such as psoriasis, neurodermatitis and hives. It is...
Jun 10, 2020 | Development / Dossiers
Polypharma has developed a Terbinafine 250mg tablet. Terbinafine is an antimycotic and is the most common medication for skin and foot fungus.
May 5, 2020 | Development / Dossiers
Polypharma has recently developed Thiocolchicoside 4mg capsules. Thiocolchicoside is a muscle relaxant with anti-inflammatory, analgesic and antispasmodic effects. It acts as a competitive GABAA receptor antagonist and also as a glycine receptor antagonist and to a...
Feb 3, 2020 | Development / Dossiers
Polypharma has completed the development of a Pregabalin 300mg capsule dossier
Jan 20, 2020 | Development / Dossiers
Fusidic Acid Cream has been added to the Polypharma dossier portfolio
